The low proportion of CD3+CD4+CD161+ T cells was significantly associated with a higher risk of infection before engraftment (cutoff of 3.72%, RR of 0.20, and P = 0.014) and CMV reactivation (cutoff of 3.72%, RR of 0.25, and P = 0.010). This evidence concerns the gene KLRB1 and infection.